Innovative Biotechnology Solutions for Buffering Needs in the Industry
2025-01-15 07:34:16 By : admin
As the biotechnology industry continues to advance, the demand for innovative solutions to meet industry needs is at an all-time high. Beijing Chuanyi Biotechnology Co., Ltd. is at the forefront of this movement, offering a wide range of cutting-edge products and services for cell and gene therapy (CGT) customers.
With a strong focus on research and development, the company has invested heavily in the production of GMP-grade raw materials and reagents for use in CGT. These products include cell separation and activation magnetic beads, eukaryotic/prokaryotic recombinant protein, serum-free medium, cell culture kits, and more. The company's commitment to providing a total solution for its customers is evident in its state-of-the-art research and development laboratory and GMP level clean workshop, covering an impressive 3200m².
One of the key highlights of Beijing Chuanyi Biotechnology Co., Ltd. is its dedication to quality and regulatory standards. The company is in conformity with both ISO13485 and ISO9001 Quality Management System Standards, ensuring that its products meet the highest level of quality and safety. In addition, some of the company's products have been FDA DMF filed, further demonstrating its commitment to compliance and regulatory requirements.
With a strong reputation for innovation and quality, Beijing Chuanyi Biotechnology Co., Ltd. continues to lead the way in providing advanced biotechnology solutions for the industry. The company's expertise in cell separation magnetic beads development, eukaryotic and prokaryotic protein expression engineering, and serum-free medium development has positioned it as a trusted partner for CGT customers.
As the biotechnology industry continues to evolve, the need for reliable and high-quality raw materials and reagents has never been greater. Beijing Chuanyi Biotechnology Co., Ltd. stands ready to meet this demand with its comprehensive range of products and services, backed by a strong commitment to quality, innovation, and customer satisfaction. With its impressive research and development capabilities and adherence to strict regulatory standards, the company is well-positioned to continue making significant contributions to the advancement of biotechnology and the CGT industry.